Form 4: Cencora Inc. Executive Chairman Steven Collis Reports Stock Transactions

Steven H. Collis, Executive Chairman of Cencora, Inc., reports the sale and acquisition of common stock and the exercise of stock options on February 27, 2025.

Summary

• On February 27, 2025, Steven H. Collis, the Executive Chairman of Cencora, Inc., engaged in multiple transactions involving the company's common stock.
• Collis sold 2,000 shares of common stock at a price of $251.08 per share.
• He also exercised non-qualified stock options to acquire 12,579 shares at an exercise price of $86.09.
• Following the exercise of options, Collis sold 12,579 shares at $251.08 per share.
• After these transactions, Collis directly owns 319,912.665 shares of Cencora, Inc.
• The sale of stock was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 25, 2024.
• Collis also directly owns 163,520 non-qualified stock options.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency to investors regarding insider trading activities.

Comparison to Industry Standards

• Executive stock transactions are a normal part of corporate governance in publicly listed companies like Cencora.
• Similar transactions are regularly reported by executives at comparable companies such as McKesson, Cardinal Health, and AmerisourceBergen.
• The use of Rule 10b5-1 trading plans is a common practice to avoid accusations of insider trading, aligning with industry best practices.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
• The disclosure provides transparency to stakeholders regarding insider trading activities.

Key Dates